down arrow

Granules India

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE101D01020
  • NSEID: GRANULES
  • BSEID: 532482
INR
451.00
20 (4.64%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 22.23 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

442.60455.60

52 Week

382.05724.55
Valuation
Technical
Day's Volume

CASH

22.23 lacs (133.26%) Volume

Shareholding (Mar 2025)

FII

15.15%

Held by 154 FIIs

DII

22.45%

Held by 29 DIIs

Promoter

38.84%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 11.29% and Operating profit at 13.03% over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 10,936 Cr (Mid Cap)

stock-summary
P/E

22.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.35%

stock-summary
Debt Equity

0.26

stock-summary
Return on Equity

14.21%

stock-summary
Price to Book

3.05

Revenue and Profits (1 Year):
Net Sales:
1,138 Cr
(Quarterly Results - Dec 2024)
Net Profit:
118 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.35%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-25.26%
0%
-25.26%
1 Year
5.67%
0.35%
6.02%
2 Years
53.61%
0.98%
54.59%
3 Years
45.39%
1.58%
46.97%
4 Years
32.1%
1.63%
33.73%
5 Years
166.39%
3.77%
170.16%

Latest dividend: 1.5 per share ex-dividend date: Jul-30-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.29%
EBIT Growth (5y)
13.03%
EBIT to Interest (avg)
15.33
Debt to EBITDA (avg)
1.33
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.05
Tax Ratio
24.93%
Dividend Payout Ratio
8.97%
Pledged Shares
0
Institutional Holding
37.59%
ROCE (avg)
19.16%
ROE (avg)
17.59%
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
33
Price to Book Value
3.05
EV to EBIT
15.45
EV to EBITDA
11.95
EV to Capital Employed
2.63
EV to Sales
2.54
PEG Ratio
1.03
Dividend Yield
0.35%
ROCE (Latest)
17.59%
ROE (Latest)
14.21%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 27 Schemes (11.57%)

FIIs

Held by 154 FIIs (15.15%)

Promoter with highest holding

Krishna Prasad Chigurupati (31.66%)

Highest Public shareholder

Life Insurance Corporation Of India (5.27%)

Individual Investors Holdings

16.07%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 17.70% vs -18.07% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 20.95% vs -27.79% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,137.70",
          "val2": "966.62",
          "chgp": "17.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "230.30",
          "val2": "203.32",
          "chgp": "13.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "26.57",
          "val2": "25.67",
          "chgp": "3.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "117.60",
          "val2": "97.23",
          "chgp": "20.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.32%",
          "val2": "21.26%",
          "chgp": "-0.94%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -1.31% vs 0.22% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 54.58% vs -44.98% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,146.48",
          "val2": "2,175.00",
          "chgp": "-1.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "462.58",
          "val2": "349.79",
          "chgp": "32.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "52.69",
          "val2": "48.42",
          "chgp": "8.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "231.88",
          "val2": "150.01",
          "chgp": "54.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.76%",
          "val2": "16.11%",
          "chgp": "5.65%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -1.39% vs 0.43% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 26.78% vs -30.56% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,284.18",
          "val2": "3,330.59",
          "chgp": "-1.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "692.88",
          "val2": "600.27",
          "chgp": "15.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "79.26",
          "val2": "77.07",
          "chgp": "2.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "349.48",
          "val2": "275.66",
          "chgp": "26.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.10%",
          "val2": "18.02%",
          "chgp": "3.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -0.12% vs 19.84% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -21.54% vs 25.16% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,506.37",
          "val2": "4,511.92",
          "chgp": "-0.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "855.98",
          "val2": "913.82",
          "chgp": "-6.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "105.82",
          "val2": "55.93",
          "chgp": "89.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "405.31",
          "val2": "516.60",
          "chgp": "-21.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.06%",
          "val2": "20.25%",
          "chgp": "-1.19%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
1,137.70
966.62
17.70%
Operating Profit (PBDIT) excl Other Income
230.30
203.32
13.27%
Interest
26.57
25.67
3.51%
Exceptional Items
0.00
0.00
Consolidate Net Profit
117.60
97.23
20.95%
Operating Profit Margin (Excl OI)
20.32%
21.26%
-0.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 17.70% vs -18.07% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 20.95% vs -27.79% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
2,146.48
2,175.00
-1.31%
Operating Profit (PBDIT) excl Other Income
462.58
349.79
32.25%
Interest
52.69
48.42
8.82%
Exceptional Items
0.00
0.00
Consolidate Net Profit
231.88
150.01
54.58%
Operating Profit Margin (Excl OI)
21.76%
16.11%
5.65%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -1.31% vs 0.22% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 54.58% vs -44.98% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3,284.18
3,330.59
-1.39%
Operating Profit (PBDIT) excl Other Income
692.88
600.27
15.43%
Interest
79.26
77.07
2.84%
Exceptional Items
0.00
0.00
Consolidate Net Profit
349.48
275.66
26.78%
Operating Profit Margin (Excl OI)
21.10%
18.02%
3.08%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -1.39% vs 0.43% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 26.78% vs -30.56% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
4,506.37
4,511.92
-0.12%
Operating Profit (PBDIT) excl Other Income
855.98
913.82
-6.33%
Interest
105.82
55.93
89.20%
Exceptional Items
0.00
0.00
Consolidate Net Profit
405.31
516.60
-21.54%
Operating Profit Margin (Excl OI)
19.06%
20.25%
-1.19%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -0.12% vs 19.84% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -21.54% vs 25.16% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Granules India Ltd stock-summary
stock-summary
Granules India Ltd
Mid Cap
Pharmaceuticals & Drugs
Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD). With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in `first line of defense' products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin.
Company Coordinates stock-summary
Company Details
Second Floor Block III, My Home Hub Madhapur Hyderabad Telangana : 500081
stock-summary
Tel: 91-40-66760000
stock-summary
http://www.granulesindia.com
stock-summary
investorrelations@granulesindia.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."